Jean Jacques Bienaime
Director · 13 filings · Latest: Jun 15, 2026
Ascendis Pharma A/S
Immunome Inc.
INCYTE CORP
Keros Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KROS | Jean Jacques Bienaime | Director | Jun 15, 2026 | Purchase | $10.19 | 1,000 | $10.2K | 17,592 | |
IMNM | Jean Jacques Bienaime | Director | Jun 5, 2026 | Purchase | $19.45 | 10,500 | $204.3K | 43,415 | |
IMNM | Jean Jacques Bienaime | Director | Jun 5, 2026 | Sale | $19.41 | 10,500 | $203.8K | 32,915 | |
ASND | Jean Jacques Bienaime | Director | May 29, 2026 | Purchase | $223.12 | 500 | $111.6K | 900 | |
INCY | Jean Jacques Bienaime | Director | May 26, 2026 | Option Exercise | $84.53 | 15,000 | $1.3M | 35,841 | |
ASND | Jean Jacques Bienaime | Director | May 26, 2026 | Purchase | $237.80 | 400 | $95.1K | 400 | |
KROS | Jean Jacques Bienaime | Director | May 15, 2026 | Purchase | $10.58 | 1,000 | $10.6K | 9,450 | |
IMNM | Jean Jacques Bienaime | Director | May 15, 2026 | Purchase | $20.70 | 5,000 | $103.5K | 43,415 | |
KROS | Jean Jacques Bienaime | Director | Apr 15, 2026 | Purchase | $11.70 | 1,000 | $11.7K | 8,450 | |
IMNM | Jean Jacques Bienaime | Director | Mar 11, 2026 | Purchase | $21.55 | 1,000 | $21.6K | 38,415 | |
IMNM | Jean Jacques Bienaime | Director | Mar 10, 2026 | Purchase | $22.12 | 1,000 | $22.1K | 37,415 | |
KROS | Jean Jacques Bienaime | Director | Mar 9, 2026 | Purchase | $11.21 | 2,000 | $22.4K | 7,450 |